Mongolia vs Singapore: The number of people with susceptibility test result for rifampicin
Mongolia
1,106
in 2021
Singapore
1,051
in 2021
Mongolia rank
64th
Singapore rank
65th
The number of people with susceptibility test result for rifampicin over time
- Mongolia
- Singapore
How they compare
Mongolia currently reports 1,106 against 1,051 in Singapore, a difference of 55.
That makes Mongolia's figure about 1.1 times Singapore's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Singapore ahead.
Mongolia ranks 64th and Singapore ranks 65th of 155 countries.
Mongolia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mongolia | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,235 | 1,090 | 144.33 | Mongolia |
| 2020s | 1,359 | 1,058 | 300.5 | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Mongolia or Singapore?
- Mongolia, at 1,106 against 1,051 in Singapore as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Mongolia and Singapore?
- 55, with Mongolia ahead.
- How many years of comparable data are there for Mongolia and Singapore?
- 5 years are reported by both, from 2017 to 2021.
- How do Mongolia and Singapore rank globally for the number of people with susceptibility test result for rifampicin?
- Mongolia ranks 64th and Singapore ranks 65th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.